Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement.
OBJECTIVE
To evaluate the functional response of the kidney to an amino acid challenge (the so called renal functional reserve (RFR)) in patients with systemic sclerosis (SSc) with no clinical sign of renal involvement.


METHODS
Before and after an intravenous amino acid load (Freamine III Baxter, 8.5% solution, 4.16 ml/min for two hours), glomerular filtration rate (GFR, as creatinine clearance), effective renal plasma flow (ERPF, as para-aminohyppurate clearance), and calculated total renal vascular resistance (TRVR) were measured in 21 patients with SSc with apparently normal renal function and 10 normal controls.


RESULTS
In basal conditions, patients had lower ERPF (403.5 (SD 43.8) v 496.4 (SD 71.3) ml/min, p<0.0002) and higher TRVR (10 822 (SD 2044) v 8874 (SD 1639) dyne/sxcm(-5), p<0.014) than controls. The RFR, evaluated as the percentage increase of GFR after the amino acid load, was significantly reduced in patients with SSc (SSc +1.9 (SD18.6)%, controls +34.8 (SD 13.9)%; p<0.0002). However, the response of patients was not uniform. Multiple regression analysis showed that the RFR was inversely dependent on the patients' mean arterial pressure at admission and basal GFR (R(2)=65%, p<0.0001).


CONCLUSIONS
Most patients with SSc cannot increase renal filtration under the challenge of a protein overload. This defective renal response to the amino acid load test sustains the concept of the prevalence of vasoconstrictor over vasodilating factors in the kidney of these patients.
Livi
R
R
Department of Internal Medicine, Section of Rheumatology and Nephrology, University of Firenze, Italy. rlivi@unifi.it
Teghini
L
L
Pignone
A
A
Generini
S
S
Matucci-Cerinic
M
M
Cagnoni
M
M
D000596:Amino Acids / Q000494:pharmacology; D001794:Blood Pressure / Q000502:physiology; D004573:Electrolytes; D005260:Female; D005919:Glomerular Filtration Rate / Q000502:physiology*; D005947:Glucose; D006801:Humans; D008297:Male; D008875:Middle Aged; D057947:Parenteral Nutrition Solutions; D012044:Regression Analysis; D017596:Renal Plasma Flow, Effective / Q000502:physiology; D012595:Scleroderma, Systemic / Q000503:physiopathology*; D012996:Solutions
D000596:Amino Acids; D004573:Electrolytes; D057947:Parenteral Nutrition Solutions; D012996:Solutions; C545824:amino-acid, glucose, and electrolyte solution; D005947:Glucose